Literature DB >> 23372313

Interventional radiological treatment of hepatocellular carcinoma: an update.

Anurag Shrimal1, Madhu Prasanth, A V Kulkarni.   

Abstract

Hepatocellular carcinoma is the commonest primary liver tumor and its incidence is on an increase.Transplantation and surgical resection are the gold standard curative treatment options but less than 20%patients are surgical candidates because of advanced liver disease and/or co-morbidities.Various interventional radiological procedures have been developed and intensively investigated for treatment of inoperable HCC.This review summarizes the various interventional radiological treatments in HCC including patient selection, procedural considerations and response evaluation. Transarterial chemoembolization, radioembolization and radiofrequency ablation are mainly discussed.

Entities:  

Keywords:  HCC; Interventional radiological treatments; Radioembolization; Radiofrequency ablation; TACE

Year:  2011        PMID： 23372313      PMCID： PMC3259173          DOI： 10.1007/s12262-011-0377-4

Source DB:  PubMed          Journal:  Indian J Surg        ISSN： 0973-9793            Impact factor:   0.656


  57 in total

1.  Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.

Authors:  Daniel B Brown; Jean-Francois H Geschwind; Michael C Soulen; Steven F Millward; David Sacks
Journal:  J Vasc Interv Radiol       Date:  2009-07       Impact factor: 3.464

2.  A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge.

Authors:  Y Sasaki; S Imaoka; H Kasugai; M Fujita; S Kawamoto; S Ishiguro; J Kojima; O Ishikawa; H Ohigashi; H Furukawa
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

3.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

Authors:  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Tomonori Fujishima; Takashi Ishikawa; Yukihiro Koike; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

Review 4.  Complications of radiofrequency coagulation of liver tumours.

Authors:  S Mulier; P Mulier; Y Ni; Y Miao; B Dupas; G Marchal; I De Wever; L Michel
Journal:  Br J Surg       Date:  2002-10       Impact factor: 6.939

5.  Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.

Authors:  Katerina Malagari; Mary Pomoni; Alexis Kelekis; Anastasia Pomoni; Spyros Dourakis; Themis Spyridopoulos; Hippokratis Moschouris; Emmanouil Emmanouil; Spyros Rizos; Dimitrios Kelekis
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-24       Impact factor: 2.740

Review 6.  Imaging after radiofrequency ablation of hepatic tumors.

Authors:  Young-Sun Kim; Hyunchul Rhim; Hyo Keun Lim
Journal:  Semin Ultrasound CT MR       Date:  2009-04       Impact factor: 1.875

7.  Further experience in treating patients with hepatocellular carcinoma in Uganda.

Authors:  C L Olweny; E Katongole-Mbidde; S Bahendeka; D Otim; J Mugerwa; S K Kyalwazi
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

Review 8.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

Authors:  Calogero Cammà; Filippo Schepis; Ambrogio Orlando; Maddalena Albanese; Lillian Shahied; Franco Trevisani; Pietro Andreone; Antonio Craxì; Mario Cottone
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

Review 9.  Chemoembolization of hepatocellular carcinoma.

Authors:  Douglas E Ramsey; Lily Y Kernagis; Michael C Soulen; Jean-Francois H Geschwind
Journal:  J Vasc Interv Radiol       Date:  2002-09       Impact factor: 3.464

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740
View more
  9 in total

Review 1.  Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.

Authors:  Lumin Chen; Jihong Sun; Xiaoming Yang
Journal:  Cancer Lett       Date:  2015-10-22       Impact factor: 8.679

Review 2.  The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Vivek A Saraswat; Anil Arora; Ajay Duseja; Mahesh K Goenka; Deepali Jain; Premashish Kar; Manoj Kumar; Vinay Kumaran; Kunisshery M Mohandas; Dipanjan Panda; Shashi B Paul; Jeyamani Ramachandran; Hariharan Ramesh; Padaki N Rao; Samir R Shah; Hanish Sharma; Ragesh B Thandassery
Journal:  J Clin Exp Hepatol       Date:  2014-05-22

Review 3.  Locoregional and systemic therapy for hepatocellular carcinoma.

Authors:  Olumide B Gbolahan; Michael A Schacht; Eric W Beckley; Thomas P LaRoche; Bert H O'Neil; Maximilian Pyko
Journal:  J Gastrointest Oncol       Date:  2017-04

4.  Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo.

Authors:  Weilin Wang; Pengfei Huang; Lufei Zhang; Jianfeng Wei; Qingsong Xie; Qiang Sun; Xiaohu Zhou; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Cancer Sci       Date:  2013-10-14       Impact factor: 6.716

5.  A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization.

Authors:  Chang Liu; Lei Li; Wu-Sheng Lu; Hua Du; Lu-Nan Yan; Tian-Fu Wen; Wu-Ran Wei; Li Jiang; Ming-Qing Xu
Journal:  BMC Cancer       Date:  2018-02-21       Impact factor: 4.430

6.  Radiofrequency ablation guided by cone beam computed tomography for hepatocellular carcinoma: a comparative study of clinical results with the conventional spiral computed tomography-guided procedure.

Authors:  Tianshi Lyu; Jian Wang; Shoujin Cao; Li Song; Xiaoqiang Tong; Yinghua Zou
Journal:  J Int Med Res       Date:  2019-06-27       Impact factor: 1.671

Review 7.  Role of microRNAs in hepatocellular carcinoma: a clinical perspective.

Authors:  Elisa Callegari; Bahaeldin K Elamin; Silvia Sabbioni; Laura Gramantieri; Massimo Negrini
Journal:  Onco Targets Ther       Date:  2013-09-02       Impact factor: 4.147

Review 8.  Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.

Authors:  A Kornberg
Journal:  ISRN Hepatol       Date:  2014-03-04

9.  Transcatheter Intra-Arterial Infusion Combined with Interventional Photothermal Therapy for the Treatment of Hepatocellular Carcinoma.

Authors:  Jun Zhou; Gonghao Ling; Jia Cao; Xun Ding; Xingnan Liao; Meng Wu; Xinyu Zhou; Haibo Xu; QingYun Long
Journal:  Int J Nanomedicine       Date:  2020-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.